Health Condition 1: L309- Dermatitis, unspecified
Conditions
Interventions
Intervention1: Panchatikta ghrita internally and Nalapamaradi taila externally: Panchatikta ghrita 6 g twice daily internally(orally) with luke warm water for 12 weeks
Nalapamaradi taila 20ml (approxi
Sponsors
Central Council for Research in Ayurvedic Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex with age between 18 and 60 years 2. Known cases of eczema (based on Hanifin and Rajka Criteria for Atopic Dermatitis/ Atopic Eczema). 3. Patients willing and able to participate in the study
Exclusion criteria
Exclusion criteria: 1. Patient with Status Eczematous condition. 2. Patient with poorly controlled Hypertension ( >160/100 mmHg) 3. Patient with uncontrolled Diabetes Mellitus having HbA1C > 8% 4. Patient on medication with corticosteroids, phototherapy, biologics, antidepressants and any other drugs that may have an influence on the outcome of the study. 5. Alcoholic and/or drug abuser 6. Symptomatic patients with clinical evidence of heart failure. 7. Known case of HIV and AIDS. 8. Known case of Malignacy. 9. Patienttaking participation in any other clinical trial. 10. Woman who are planning for conception/pregnant or lactating. 11. Patientwith concurrent serious hepatic disorders (defined as aspartate amino (AST) and/ or Alanine AminoTransferase(ALT) >2times upper normal limit or Renal Disorders (defined as S. Creatinine >1.2mg/dl), Severe pulmonary Dysfunction (uncontrolled Bronchial Asthma and /or Chronic obstructive Pulmonary Disease (COPD). 12. H/o hypersensitivity to any of the trial drugs or their ingredients. 13. Patient who have completed participation in any other clinical trial during the past three months. 14. Any other condition which the Investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Eczema Area Severity Index score (EASI) Change in Patient Oriented Eczema measure (POEM) Change in Dermatology life Quality Index (DLQI ) Questionnaire score Timepoint: At Baseline, 14th day, 28th day, 42th day, 56th day, 70th day, 84th day and 112th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Signs & Symptoms.Timepoint: At Baseline, 14th day, 28th day, 42th day, 56th day, 70th day, 84th day and 112th day | — |
Countries
India
Contacts
Public ContactMidhuna Mohan K
Regional Ayurveda Research Institute for Skin Disorders, Vijayawada under CCRAS
Outcome results
None listed